1. Cell-based glycoengineering of extracellular vesicles through precise genome editing.
- Author
-
Tian, Weihua, Zagami, Chiara, Chen, Jiasi, Blomberg, Anne Louise, Guiu, Laura Salse, Skovbakke, Sarah Line, and Goletz, Steffen
- Subjects
- *
GLYCAN structure , *EXTRACELLULAR vesicles , *GENE expression , *GENOME editing , *GLYCOSYLATION , *GLYCANS - Abstract
Engineering of extracellular vesicles (EVs) towards more efficient targeting and uptake to specific cells has large potentials for their application as therapeutics. Carbohydrates play key roles in various biological interactions and are essential for EV biology. The extent to which glycan modification of EVs can be achieved through genetic glycoengineering of their parental cells has not been explored yet. Here we introduce targeted glycan modification of EVs through cell-based glycoengineering via modification of various enzymes in the glycosylation machinery. In a "simple cell" strategy, we modified major glycosylation pathways by knocking-out (KO) essential genes for N-glycosylation (MGAT1), O-GalNAc glycosylation (C1GALT1C1), glycosphingolipids (B4GALT5/6), glycosaminoglycans (B4GALT7) and sialylation (GNE) involved in the elongation or biosynthesis of the glycans in HEK293F cells. The gene editing led to corresponding glycan changes on the cells as demonstrated by differential lectin staining. Small EVs (sEVs) isolated from the cells showed overall corresponding glycan changes, but also some unexpected differences to their parental cell including enrichment preference for certain glycan structures and absence of other glycan types. The genetic glycoengineering did not significantly impact sEVs production, size distribution, or syntenin-1 biomarker expression, while a clonal influence on sEVs production yields was observed. Our findings demonstrate the successful implementation of sEVs glycoengineering via genetic modification of the parental cell and a stable source for generation of glycoengineered sEVs. The utilization of glycoengineered sEVs offers a promising opportunity to study the role of glycosylation in EV biology, as well as to facilitate the optimization of sEVs for therapeutic purposes. • Glycan modification of sEVs can be accomplished by genetic glycoengineering the cells from which they originate. • Glycan alterations on sEVs are not always in line with those found on their parental cells. • Glycoengineering of cells does not significantly affect the production, size, or expression of biomarkers on sEVs. • Cell-based glycoengineering enables the stable large-scale production of glycoengineered sEVs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF